CSI Market
Sign In | Register

U s Stem Cell Inc (USRM) Quarterly Cash Flow Statement

Quarterly · GAAP · USD millions
Access USRM Annual Cash Flow →
Cash flow patterns shown here provide context for understanding U s Stem Cell Inc's ability to sustain operations and capital deployment.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Dec 31 2022)
12 Months 		(Sep 30 2022) (Jun 30 2022) (Mar 31 2022) (Dec 31 2021)
Operating Activities
Income-2.86
Depreciation & amortization0.00
Amortization of Other Assets0.69
Increase (Decrease) in Deferred Revenue0.00
Restructuring & Impairment Charges0.00
Provision For Loan Losses Expensed0.00
Increase (Decrease) in Inventories0.00
R & D, Environmental and Other Expense0.00
Gain (Loss) on Disposition of Property Plant Equipment0.00
Share-based Compensation0.38
Income (Loss) from Equity Method Investments0.00
Financial Instruments and Foreign Currency Transaction0.47
Gain Loss On Derivative Instruments Net Pretax-
Amortization Of Warrants Issued In Exchange For Licenses And Intellectual Property-
Amortization Of Warrants Issued In Connection With Notes Payable-
Common Stock Issued In Connection With Accounts Payable And Accrued Interest-
Common Stock Issued In Exchange For Services-
Common Stock Issued In Connection With Amounts Due To Guarantors Of Bank Of America Loan-
Common Stock Issued In Exchange For Distribution Rights And Intellectual Property-
Gain Loss Related To Litigation Settlement0.38
Issue Of Warrants In Connection With Joint Venture Agreement And Intellectual Property-
Capital Leases Income Statement Interest Expense-
Adjustments To Additional Paid In Capital Other0.38
Gains Losses On Restructuring Of Debt0.00
Income taxes0.00
Losses/ -gains on Investments net0.00
Increase (Decrease) in Receivables0.00
Increase (Decrease) in Accounts Payable0.27
Increase (Decrease) in Accrued Liabilities0.02
Deferred Revenue and Customer Advances and Deposits0.00
Increase (Decrease) in Prepaid Expense and Other Assets0.00
Other Working Capital0.00
Other Noncash Income (Expense)0.00
Other net0.00
Payments for (Proceeds from) Other Operating Activities0.73
Discontinued operations0.00
Net Cash flow from Operating Activities-0.30
Investing Activities
Capital Expenditures0.00
Sale of Capital Items0.00
Short-term Investments Proceeds0.00
Short-term Investments Acq.0.00
Real Estate Investments0.00
Purchase Of Treasury Stock-
Restricted Cash and Investments Increase (Decrease)0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Payments for (Proceeds from) Other Investments0.00
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Acquisition Net of Cash Acquired0.00
Interest in Subsidiaries and Affiliates0.00
Sale of businesses0.00
Accounts payable0.00
Receivables0.00
Payments for (Proceeds from) Other Investing Activities0.00
Other Net0.00
Discontinued operations0.00
Net Cash Flow from Investing Activities0.00
Financing Activities
Short-term debt Net0.00
Other borrowing transactions0.00
Long-term debt - borrowings0.00
Long-term debt - repayments0.00
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock0.00
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock0.00
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net0.00
Other net0.00
Payment Of Note Payable-
Proceeds From Notes Payable Related Party-
Proceeds From Related Party Advances-
Bank Overdraft-
Proceeds From Repayments Of Related Party Advances-
Proceeds From Stock Options Exercised And Warrants-
Net Proceeds From Common Stock Subscriptions-
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities0.00
Effect of exchange rate on cash flow0.00
Discontinued operations0.00
Free Cash Flow-0.30
Total Cash Flow0.00
4 historic quarters locked

Sign in to unlock the full U s Stem Cell Inc cash flow history.

Sign In Create Free Account

About U s Stem Cell Inc Quarterly Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC filings and normalized by CSIMarket.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0001185185-23-000339

Figures are derived from filed reports and may be restated. Historical data is subject to revision.